IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Medicamen Biotech

NSE:MEDICAMEQ · ISIN INE646B01010

Close
₹238.2
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Medicamen Biotech

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Trading Window - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Disclosure under SEBI Takeover Regulations - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Compliances - Regulation 32 (1) And (3) - Statament Of Deviation & Variation Report - March 2026BSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Statement of deviation(s) or variation(s) under Reg. 32 - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Audited Stabdalone & Consolidated Financial Results For The Quarter And Year Ended On March 31, 2026BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Medicamen Biotech LimitedNSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated ) For The Quarter And Year Ended On March 31, 2026BSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL PortalBSE · exchange filing · pdf
Source filing
Disclosure of material issue - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Trading Window - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015BSE · exchange filing · pdf
Source filing
General Updates - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing
Corrigendum - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Unaudited Financial Results For The Quarter Ended On December 31, 2025BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Medicamen Biotech LimitedNSE · financial results · pdf
Source filing
Change in Management - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Outcome of Board Meeting - Medicamen Biotech LimitedNSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025.BSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement Under Regulation 30 (LODR)- EU Approval For Product Registration Of ParacetamolBSE · exchange filing · pdf
Source filing
Updates - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Closure of Trading WindowBSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Medicamen Biotech LimitedNSE · exchange filing · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Financial Results For The Quarter And Half Year Ended On September 30, 2025BSE · financial results · pdf
Source filing
Outcome of Board Meeting - Medicamen Biotech LimitedNSE · financial results · pdf
Source filing
Medicamen Biotech Ltd-$ - 531146 - Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2025BSE · financial results · pdf
Source filing